319 related articles for article (PubMed ID: 29344766)
1. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
Nieder C; Kämpe TA
Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
[TBL] [Abstract][Full Text] [Related]
3. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison.
Nieder C; Dalhaug A; Pawinski A; Haukland E; Mannsåker B; Engljähringer K
Radiat Oncol; 2015 Mar; 10():61. PubMed ID: 25889414
[TBL] [Abstract][Full Text] [Related]
6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy.
Nieder C; Kämpe TA
Cureus; 2018 Jan; 10(1):e2032. PubMed ID: 29535905
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.
Chow E; Davis L; Holden L; Tsao M; Danjoux C
J Pain Symptom Manage; 2005 Jul; 30(1):18-23. PubMed ID: 16043003
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported symptoms during radiotherapy : Clinically relevant symptom burden in patients treated with palliative and curative intent.
Körner P; Ehrmann K; Hartmannsgruber J; Metz M; Steigerwald S; Flentje M; van Oorschot B
Strahlenther Onkol; 2017 Jul; 193(7):570-577. PubMed ID: 28573475
[TBL] [Abstract][Full Text] [Related]
10. Managing brain metastases patients with and without radiotherapy: initial lessonsfrom a team-based consult service through a multidisciplinary integrated palliative oncology clinic.
Jung H; Sinnarajah A; Enns B; Voroney JP; Murray A; Pelletier G; Wu JS
Support Care Cancer; 2013 Dec; 21(12):3379-86. PubMed ID: 23934224
[TBL] [Abstract][Full Text] [Related]
11. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer.
Zeng L; Zhang L; Culleton S; Jon F; Holden L; Kwong J; Khan L; Tsao M; Danjoux C; Sahgal A; Barnes E; Chow E
J Palliat Med; 2011 Mar; 14(3):337-42. PubMed ID: 21254813
[TBL] [Abstract][Full Text] [Related]
12. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Zhao F; Ding G; Huang W; Li M; Fu Z; Yang G; Kong L; Zhang Y; Yu J
Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696
[TBL] [Abstract][Full Text] [Related]
14. Symptom Burden in Patients With Reduced Performance Status at the Start of Palliative Radiotherapy.
Nieder C; Kämpe TA
In Vivo; 2020; 34(2):735-738. PubMed ID: 32111778
[TBL] [Abstract][Full Text] [Related]
15. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
[TBL] [Abstract][Full Text] [Related]
16. External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-life.
Mojica-Márquez AE; Rodríguez-López JL; Patel AK; Ling DC; Rajagopalan MS; Beriwal S
Cancer Med; 2020 Aug; 9(16):5781-5787. PubMed ID: 32592315
[TBL] [Abstract][Full Text] [Related]
17. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
[TBL] [Abstract][Full Text] [Related]
18. Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Narducci F; Grande R; Mentuccia L; Trapasso T; Sperduti I; Magnolfi E; Fariello AM; Gemma D; Gamucci T
Support Care Cancer; 2012 Jun; 20(6):1221-6. PubMed ID: 21688165
[TBL] [Abstract][Full Text] [Related]
19. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
